Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up to $220 million in milestones. Pfizer’s decision sent ...

As the clock struck midnight in New Zealand, Auckland welcomed the arrival of 2025 with its traditional fireworks display at the iconic Sky Tower. Revellers set up camp by the water, at Mrs ...

[RUNGROJ YONGRIT/EPA] A person takes photos of the crowd gathered prior to the firework display at Taiwan's Taipei 101 tower. [RITCHIE B TONGO/EPA] 1 January is a major national holiday in Japan ...

De­spite re­port­ing a Phase 3 win this sum­mer, Pfiz­er ter­mi­nat­ed its he­mo­phil­ia A gene ther­a­py pact with Sang­amo … ...

The two drugmakers were working on a treatment for hemophilia in adults. Sangamo said it would explore other options, including finding another partner. Sangamo Therapeutics (SGMO) shares cratered ...

A rare genetic blood disorder, hemophilia is caused by a missing clotting protein Factor VIII (FVIII) in hemophilia A, which prevents normal blood clotting. If the blood does not clot properly ...

Credit: jayk7 via Getty Images. Sangamo Therapeutics’ stock has plummeted by 50% in premarket trading after Pfizer ended the companies’ partnership to co-develop a gene therapy for haemophilia A.

(Bloomberg) -- Sangamo Therapeutics Inc. shares fell the most in 16 years after Pfizer Inc. ended the two companies’ partnership to develop a new gene therapy to treat hemophilia A. Sangamo is ...

When TIME’s photo department got together to create our annual list of the year’s top 10 photos, we first had to tackle the definition of an influential photo. Because those images gained so ...

Dec 30 (Reuters) - Sangamo Therapeutics (SGMO.O), opens new tab said on Monday that partner Pfizer (PFE.N), opens new tab has terminated their hemophilia A gene therapy co-development agreement ...

Newly released pictures show then-Vice President Joe Biden meeting some of his son Hunter Biden’s Chinese business partners during an official visit to the country, as well as Hunter meeting ...

This is the reality for people with severe haemophilia A. But a groundbreaking study from India may offer a life-changing solution. Researchers tested a new gene therapy on five men, aged 22 to 41 ...